Loading song details...
177Lu Rosopatamab An Antibody Based PSMA Radioligand In Prostate Cancer
No description available.
MP3 Download
Video Download
Related Songs
2:15
177Lu Rosopatamab An Antibody Based PSMA Radioligand In Prostate Cancer
3:57
ProstACT Global Part 1 177Lu Rosopatamab And Standard Of Care In MCRPC
6:45
177Lu PSMA 617 For Prostate Cancer TheraP VISION UpFrontPSMA And LuTectomy
5:37
177Lu PSMA 617 For The Early Treatment Of Prostate Cancer
1:24
LuPARP 177Lu PSMA 617 And PARP Inhibitor Combination For Prostate Cancer
3:03
VISION Tolerability Of 177Lu PSMA 617 By Treatment Exposure In Patients With MCRPC
3:23
Pedro Barata MD Highlights Phase 3 Data On 177Lu Rosopatamab Tetraxetan In MCRPC
3:56
VISION 177Lu PSMA 617 In Positive MCRPC
1:39
177Lu PSMA 617 After Sipuleucel T In MCRPC PRECISION Analysis
5:30
Fractionated Dose 177Lu PSMA 617 In Patients With MCRPC
2:46
UpFrontPSMA Trial 177Lu PSMA 617 And Docetaxel In MHNPC
1:17
PRINCE 177Lu PSMA 617 And Pembrolizumab In Prostate Cancer
8:52
MedJ Interview Prof Pedro Barata Discusses 177Lu Rosopatamab Safety Data In MCRPC
5:27
177Lu PSMA 617 Radionuclide Therapy In MCRPC
3:30
How To Administer The Investigational Radiopharmaceutical 177Lu PSMA I T
3:07
PSMA TRT 225Ac J591 And 177Lu I T In MCRPC
5:36
Anti PSMA Antibody Radiolabeled With 177Lu Improves MFS In High Risk NmCRPC
2:08
PSMAddition 177Lu PSMA 617 Plus ADT And ARPI In Positive MHSPC
5:06
Kim Chi MD On Sequencing 177Lu PSMA 617 And Docetaxel In MCRPC
1:38